CONMED Corporation (CNMD)vsEdwards Lifesciences Corp (EW)
CNMD
CONMED Corporation
$45.76
-3.05%
HEALTHCARE · Cap: $1.37B
EW
Edwards Lifesciences Corp
$91.78
+1.06%
HEALTHCARE · Cap: $49.92B
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 375% more annual revenue ($6.51B vs $1.37B). EW leads profitability with a 15.4% profit margin vs 4.1%. CNMD appears more attractively valued with a PEG of 1.84. CNMD earns a higher WallStSmart Score of 57/100 (C).
CNMD
Buy57
out of 100
Grade: C
EW
Buy55
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+26.9%
Fair Value
$57.90
Current Price
$45.76
$12.14 discount
Margin of Safety
+68.5%
Fair Value
$251.45
Current Price
$91.78
$159.67 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Strong operational efficiency at 29.8%
Areas to Watch
Expensive relative to growth rate
0.3% revenue growth
Distress zone — elevated risk
Smaller company, higher risk/reward
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 25.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : CNMD
The strongest argument for CNMD centers on Price/Book.
Bull Case : EW
The strongest argument for EW centers on Debt/Equity, Altman Z-Score, Operating Margin. Profitability is solid with margins at 15.4% and operating margin at 29.8%. Revenue growth of 13.6% demonstrates continued momentum.
Bear Case : CNMD
The primary concerns for CNMD are PEG Ratio, Revenue Growth, Altman Z-Score. Thin 4.1% margins leave little buffer for downturns.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 51.5x leaves little room for execution misses.
Key Dynamics to Monitor
CNMD profiles as a value stock while EW is a mature play — different risk/reward profiles.
CNMD carries more volatility with a beta of 0.94 — expect wider price swings.
EW is growing revenue faster at 13.6% — sustainability is the question.
EW generates stronger free cash flow (585M), providing more financial flexibility.
Bottom Line
CNMD scores higher overall (57/100 vs 55/100). EW offers better value entry with a 68.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CONMED Corporation
HEALTHCARE · MEDICAL DEVICES · USA
CONMED Corporation, a medical technology company, develops, manufactures and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company is headquartered in Largo, Florida.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?